| Product Code: ETC8842868 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Philippines saw an increasing trend in hemostats import shipments in 2024, with key exporters including China, Vietnam, Japan, Colombia, and Thailand. Despite this diverse sourcing, the market maintained a moderate concentration with the Herfindahl-Hirschman Index (HHI). The impressive compound annual growth rate (CAGR) of 18.67% from 2020 to 2024 signifies a robust market expansion, further supported by a notable growth rate of 23.11% in 2024. This data suggests a thriving market for hemostats in the Philippines, driven by a mix of international suppliers.

The hemostats market in the Philippines is seeing growth due to advancements in surgical procedures and emergency care. Hospitals and clinics are increasingly adopting advanced hemostatic agents to control bleeding and improve surgical outcomes. The market is benefiting from rising investments in healthcare infrastructure.
The growing number of surgical procedures and trauma cases in the Philippines is driving the demand for hemostats. The increasing adoption of advanced wound care solutions and minimally invasive surgeries has contributed to market expansion. Additionally, government initiatives to improve emergency medical services and hospital infrastructure further support market growth.
The hemostats market in the Philippines faces hurdles due to high import dependence, leading to increased costs for hospitals and medical facilities. Limited awareness among healthcare professionals about the benefits of advanced hemostatic agents also slows adoption. Additionally, regulatory challenges in approving new hemostatic products delay market entry.
The growing number of surgical procedures and the increasing focus on blood loss management in operating rooms are driving the hemostats market in the Philippines. Investment opportunities lie in advanced hemostatic agents, absorbable hemostats, and innovations in minimally invasive surgery. The demand for cost-effective and efficient bleeding control solutions presents further growth potential.
The Philippine government prioritizes healthcare advancements, benefiting the hemostats market. The DOH and FDA regulate the approval and distribution of medical devices, ensuring the safety and efficacy of hemostatic products. Public hospital funding and procurement programs support the acquisition of advanced medical supplies, increasing accessibility to hemostatic agents for surgeries and trauma care. Additionally, incentives for local medical device manufacturers promote domestic production, reducing reliance on imports.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Hemostats Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Hemostats Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Hemostats Market - Industry Life Cycle |
3.4 Philippines Hemostats Market - Porter's Five Forces |
3.5 Philippines Hemostats Market Revenues & Volume Share, By Product type, 2021 & 2031F |
3.6 Philippines Hemostats Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.7 Philippines Hemostats Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Philippines Hemostats Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Philippines Hemostats Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgical procedures in the Philippines |
4.2.2 Growing prevalence of chronic diseases requiring surgery |
4.2.3 Technological advancements leading to the development of more effective hemostats |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure in certain regions of the Philippines |
4.3.2 High costs associated with advanced hemostatic products |
4.3.3 Stringent regulatory requirements for approval of hemostats in the market |
5 Philippines Hemostats Market Trends |
6 Philippines Hemostats Market, By Types |
6.1 Philippines Hemostats Market, By Product type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Hemostats Market Revenues & Volume, By Product type, 2021- 2031F |
6.1.3 Philippines Hemostats Market Revenues & Volume, By Combination, 2021- 2031F |
6.1.4 Philippines Hemostats Market Revenues & Volume, By Oxidized regenerated cellulose based, 2021- 2031F |
6.1.5 Philippines Hemostats Market Revenues & Volume, By Gelatine based, 2021- 2031F |
6.1.6 Philippines Hemostats Market Revenues & Volume, By Collagen based haemostat, 2021- 2031F |
6.2 Philippines Hemostats Market, By Formulation |
6.2.1 Overview and Analysis |
6.2.2 Philippines Hemostats Market Revenues & Volume, By Matrix and gel hemostats, 2021- 2031F |
6.2.3 Philippines Hemostats Market Revenues & Volume, By Sheet and pad hemostats, 2021- 2031F |
6.2.4 Philippines Hemostats Market Revenues & Volume, By Sponge hemostats, 2021- 2031F |
6.2.5 Philippines Hemostats Market Revenues & Volume, By Powder hemostats, 2021- 2031F |
6.3 Philippines Hemostats Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Philippines Hemostats Market Revenues & Volume, By Closure, 2021- 2031F |
6.3.3 Philippines Hemostats Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4 Philippines Hemostats Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Philippines Hemostats Market Revenues & Volume, By Ambulatory centers, 2021- 2031F |
6.4.3 Philippines Hemostats Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Philippines Hemostats Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 Philippines Hemostats Market Revenues & Volume, By Community healthcare, 2021- 2031F |
6.4.6 Philippines Hemostats Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Hemostats Market Import-Export Trade Statistics |
7.1 Philippines Hemostats Market Export to Major Countries |
7.2 Philippines Hemostats Market Imports from Major Countries |
8 Philippines Hemostats Market Key Performance Indicators |
8.1 Adoption rate of advanced hemostatic products in hospitals and clinics |
8.2 Rate of surgical procedures using hemostats |
8.3 Number of partnerships and collaborations between hemostat manufacturers and healthcare providers |
8.4 Research and development investments in new hemostatic technologies |
8.5 Patient outcomes and recovery time post-surgery using hemostats |
9 Philippines Hemostats Market - Opportunity Assessment |
9.1 Philippines Hemostats Market Opportunity Assessment, By Product type, 2021 & 2031F |
9.2 Philippines Hemostats Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.3 Philippines Hemostats Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Philippines Hemostats Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Philippines Hemostats Market - Competitive Landscape |
10.1 Philippines Hemostats Market Revenue Share, By Companies, 2024 |
10.2 Philippines Hemostats Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |